Study finds new lethal combination of cancer drugs shrinks tumors

Controlling the time and sequence of cancer therapies may hold the key to unlocking better outcomes for patients with aggressive cancers, according to research published today.In a collaborative effort between cancer biologists at Harvard Medical School and applied mathematicians at the University of Waterloo, researchers are now showing that improved cancer therapy can be achieved by targeting drug-resistant cancer cells in a new way. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *